StrategIQ Financial Group LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Get Rating) by 9.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 767 shares of the healthcare conglomerate’s stock after acquiring an additional 67 shares during the period. StrategIQ Financial Group LLC’s holdings in UnitedHealth Group were worth $385,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. OLD Mission Capital LLC acquired a new stake in UnitedHealth Group in the 3rd quarter worth about $439,000. Camden National Bank raised its position in UnitedHealth Group by 5.5% in the fourth quarter. Camden National Bank now owns 1,902 shares of the healthcare conglomerate’s stock valued at $667,000 after purchasing an additional 100 shares during the period. Morgan Stanley raised its position in UnitedHealth Group by 9.7% in the second quarter. Morgan Stanley now owns 8,693,237 shares of the healthcare conglomerate’s stock valued at $3,481,120,000 after purchasing an additional 768,188 shares during the period. Atwood & Palmer Inc. raised its position in UnitedHealth Group by 6.0% in the third quarter. Atwood & Palmer Inc. now owns 527 shares of the healthcare conglomerate’s stock valued at $206,000 after purchasing an additional 30 shares during the period. Finally, Montecito Bank & Trust grew its stake in shares of UnitedHealth Group by 6.8% in the third quarter. Montecito Bank & Trust now owns 1,999 shares of the healthcare conglomerate’s stock worth $781,000 after acquiring an additional 128 shares in the last quarter. Hedge funds and other institutional investors own 86.07% of the company’s stock.
In other UnitedHealth Group news, Director Richard T. Burke sold 5,000 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, February 16th. The shares were sold at an average price of $476.72, for a total value of $2,383,600.00. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Paul R. Garcia purchased 2,146 shares of the firm’s stock in a transaction on Tuesday, February 22nd. The stock was acquired at an average price of $464.97 per share, for a total transaction of $997,825.62. The disclosure for this purchase can be found here. Insiders sold 23,000 shares of company stock worth $11,123,890 over the last ninety days. 0.55% of the stock is currently owned by corporate insiders.
UnitedHealth Group (NYSE:UNH – Get Rating) last announced its quarterly earnings results on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share for the quarter, beating analysts’ consensus estimates of $5.38 by $0.11. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The firm had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. During the same period in the previous year, the company posted $5.31 earnings per share. UnitedHealth Group’s revenue was up 14.2% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 21.66 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 22nd. Investors of record on Monday, March 14th were issued a $1.45 dividend. The ex-dividend date was Friday, March 11th. This represents a $5.80 annualized dividend and a yield of 1.08%. UnitedHealth Group’s dividend payout ratio is presently 31.75%.
A number of equities analysts recently commented on UNH shares. Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $563.00 to $588.00 and gave the stock an “outperform” rating in a research note on Monday. Raymond James raised their target price on UnitedHealth Group from $515.00 to $540.00 and gave the stock a “strong-buy” rating in a research report on Friday, January 21st. StockNews.com began coverage on UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Credit Suisse Group raised their target price on UnitedHealth Group from $564.00 to $595.00 and gave the stock an “outperform” rating in a research report on Monday. Finally, Truist Financial lifted their price target on UnitedHealth Group from $575.00 to $610.00 in a research report on Thursday, April 7th. Two analysts have rated the stock with a hold rating, twenty-one have given a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $529.09.
About UnitedHealth Group (Get Rating)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.
- Get a free copy of the StockNews.com research report on UnitedHealth Group (UNH)
- Levi Straus Stock Ready to Buy the Dip
- Bed Bath & Beyond Stock Ready to Scale Into
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.